97 related articles for article (PubMed ID: 16438939)
1. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
[TBL] [Abstract][Full Text] [Related]
2. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
[TBL] [Abstract][Full Text] [Related]
4. New acridone-4-carboxylic acid derivatives as potential inhibitors of hepatitis C virus infection.
Stankiewicz-Drogon A; Palchykovska LG; Kostina VG; Alexeeva IV; Shved AD; Boguszewska-Chachulska AM
Bioorg Med Chem; 2008 Oct; 16(19):8846-52. PubMed ID: 18801660
[TBL] [Abstract][Full Text] [Related]
5. Direct fluorometric measurement of hepatitis C virus helicase activity.
Boguszewska-Chachulska AM; Krawczyk M; Stankiewicz A; Gozdek A; Haenni AL; Strokovskaya L
FEBS Lett; 2004 Jun; 567(2-3):253-8. PubMed ID: 15178332
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents.
Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS
Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148
[TBL] [Abstract][Full Text] [Related]
7. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
Borowski P; Lang M; Haag A; Baier A
Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
[TBL] [Abstract][Full Text] [Related]
8. Phosphoramidate ProTides of 2'-C-methylguanosine as highly potent inhibitors of hepatitis C virus. Study of their in vitro and in vivo properties.
McGuigan C; Gilles A; Madela K; Aljarah M; Holl S; Jones S; Vernachio J; Hutchins J; Ames B; Bryant KD; Gorovits E; Ganguly B; Hunley D; Hall A; Kolykhalov A; Liu Y; Muhammad J; Raja N; Walters R; Wang J; Chamberlain S; Henson G
J Med Chem; 2010 Jul; 53(13):4949-57. PubMed ID: 20527890
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors.
Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Hsu TA; Yueh A; Chao YS; Chern JH
Bioorg Med Chem Lett; 2009 Aug; 19(15):4134-8. PubMed ID: 19539472
[TBL] [Abstract][Full Text] [Related]
10. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
Watashi K; Shimotohno K
Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
[TBL] [Abstract][Full Text] [Related]
11. Fluorometric assay of hepatitis C virus NS3 helicase activity.
Krawczyk M; Stankiewicz-Drogoń A; Haenni AL; Boguszewska-Chachulska A
Methods Mol Biol; 2010; 587():211-21. PubMed ID: 20225152
[TBL] [Abstract][Full Text] [Related]
12. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
[TBL] [Abstract][Full Text] [Related]
13. Amidinoanthracyclines - a new group of potential anti-hepatitis C virus compounds.
Krawczyk M; Wasowska-Lukawska M; Oszczapowicz I; Boguszewska-Chachulska AM
Biol Chem; 2009 Apr; 390(4):351-60. PubMed ID: 19199832
[TBL] [Abstract][Full Text] [Related]
14. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 5'-modified 2'-deoxyadenosine analogues as anti-hepatitis C virus agents.
Ikejiri M; Ohshima T; Fukushima A; Shimotohno K; Maruyama T
Bioorg Med Chem Lett; 2008 Aug; 18(16):4638-41. PubMed ID: 18644724
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy.
Borowski P; Mueller O; Niebuhr A; Kalitzky M; Hwang LH; Schmitz H; Siwecka MA; Kulikowsk T
Acta Biochim Pol; 2000; 47(1):173-80. PubMed ID: 10961691
[TBL] [Abstract][Full Text] [Related]
17. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH
Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940
[TBL] [Abstract][Full Text] [Related]
18. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
19. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
Gunic E; Girardet JL; Ramasamy K; Stoisavljevic-Petkov V; Chow S; Yeh LT; Hamatake RK; Raney A; Hong Z
Bioorg Med Chem Lett; 2007 May; 17(9):2452-5. PubMed ID: 17331721
[TBL] [Abstract][Full Text] [Related]
20. Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.
Umehara T; Fukuda K; Nishikawa F; Sekiya S; Kohara M; Hasegawa T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2004; (48):195-6. PubMed ID: 17150545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
